Pdp (68071 3989 6)
Buspirone Hydrochloride Tablet
Product Images NDC 68071-3989
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 68071-3989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structure (8b51cc64 78c9 4457 A523 161bc2049bdf 01)
Image-15mg (8b51cc64 78c9 4457 A523 161bc2049bdf 02)
This text provides instructions on how to take a 15 mg tablet based on various dosage options, which include 5 mg as the entire tablet, 10 mg as two-thirds of a tablet, 7.5 mg as one-half of a tablet, and 5 mg as one-third of a tablet. These details can be useful for patients following a prescribed medication regimen.*
Image 15mg (8b51cc64 78c9 4457 A523 161bc2049bdf 03)
Image-30mg (8b51cc64 78c9 4457 A523 161bc2049bdf 04)
This text provides guidance on how to properly take a 30 mg tablet as per the doctor's prescription. It specifically mentions the doses corresponding to different fractions of the tablet, such as two-thirds, one-half, and one-third, for the 30 mg tablet. This information can be useful for patients to accurately adhere to their prescribed dosage.*
Image 30mg (8b51cc64 78c9 4457 A523 161bc2049bdf 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
